NOUVEAU COMPOSÉ OU SON SEL PHARMACEUTIQUEMENT ACCEPTÉ

• 收藏
• 分享

专利权人:

RIKEN;Kabushiki Kaisha Yakult Honsha;Japanese Foundation For Cancer Research

发明人:

YOSHIDA, Minoru,SEIMIYA, Hiroyuki,OKUE, Masayuki,YASHIRODA, Yoko,SHIRAI, Fumiyuki,TSUMURA, Takeshi,KANO, Yuko,WASHIZUKA, Kenichi,YOSHIMOTO, Nobuko,KOUDA, Yasuko,FUKAMI, Takehiro,CHIKADA, Tsubasa,WATAN

申请号：

EP17820316

公开号：

EP3480198A4

申请日:

2017.06.30

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Provided are 2-(piperidin-1-yl)pyrimidin-4(3H)-ones or pharmaceutically acceptable salts thereof, each characterized by having a 1,8-diazaspiro[4.5]deca-3-ene, 1-oxa-8-azaspiro[4.5]deca-3-ene, 2,8-diazaspiro[4.5]deca-3-ene, 2-oxa-8-azaspiro[4.5]deca-3-ene, 2,9-diazaspiro[5.5]undeca-3-ene, 1-oxa-9-azaspiro[5.5]undeca-3-ene, 1,9-diazaspiro[5.5]undeca-4-ene, or 3,9-diazaspiro[5.5]undeca-1-ene structure represented by the following general formula (1):

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/